{"id":"NCT01949155","sponsor":"Otonomy, Inc.","briefTitle":"OTO-201 for the Treatment of Middle Ear Effusion in Pediatric Subjects Requiring Tympanostomy Tube Placement","officialTitle":"Prospective, Randomized, Double-Blind, Sham-Controlled, Multicenter, P3 Study of OTO-201 Given as a Single IT Injection For Intra-Operative Treatment of Middle Ear Effusion in Pediatric Subjects Requiring Tympanostomy Tube Placement","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-11","primaryCompletion":"2014-05","completion":"2014-05","firstPosted":"2013-09-24","resultsPosted":"2016-11-11","lastUpdate":"2016-11-11"},"enrollment":266,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Otitis Media With Effusion"],"interventions":[{"type":"DRUG","name":"OTO-201","otherNames":[]},{"type":"DRUG","name":"Sham","otherNames":[]}],"arms":[{"label":"OTO-201","type":"EXPERIMENTAL"},{"label":"Sham","type":"SHAM_COMPARATOR"}],"summary":"The purpose of this study is to confirm the effectiveness, safety and tolerability of OTO-201 in the treatment of pediatric subjects with bilateral middle ear effusion who require tympanostomy tube placement.","primaryOutcome":{"measure":"Percentage of Participants Who Were Treatment Failures.","timeFrame":"Day 15 - 2 weeks after dosing","effectByArm":[{"arm":"OTO-201","deltaMin":21.3,"sd":null},{"arm":"Sham","deltaMin":45.5,"sd":null}],"pValues":[]},"eligibility":{"minAge":"6 Months","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["26985629"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":178},"commonTop":["Pyrexia","Procedural pain","Upper respiratory tract infection","Teething","Cough"]}}